These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 14630799)
1. Hu1D10 induces apoptosis concurrent with activation of the AKT survival pathway in human chronic lymphocytic leukemia cells. Mone AP; Huang P; Pelicano H; Cheney CM; Green JM; Tso JY; Johnson AJ; Jefferson S; Lin TS; Byrd JC Blood; 2004 Mar; 103(5):1846-54. PubMed ID: 14630799 [TBL] [Abstract][Full Text] [Related]
2. PI3-kinase regulates survival of chronic lymphocytic leukemia B-cells by preventing caspase 8 activation. Plate JM Leuk Lymphoma; 2004 Aug; 45(8):1519-29. PubMed ID: 15370202 [TBL] [Abstract][Full Text] [Related]
3. Enhanced killing of B lymphoma cells by granulocyte colony-stimulating factor-primed effector cells and Hu1D10--a humanized human leucocyte antigen DR antibody. Stockmeyer B; Schiller M; Repp R; Lorenz HM; Kalden JR; Gramatzki M; Valerius T Br J Haematol; 2002 Sep; 118(4):959-67. PubMed ID: 12199773 [TBL] [Abstract][Full Text] [Related]
4. Induction of B-chronic lymphocytic leukemia cell apoptosis by arsenic trioxide involves suppression of the phosphoinositide 3-kinase/Akt survival pathway via c-jun-NH2 terminal kinase activation and PTEN upregulation. Redondo-Muñoz J; Escobar-Díaz E; Hernández Del Cerro M; Pandiella A; Terol MJ; García-Marco JA; García-Pardo A Clin Cancer Res; 2010 Sep; 16(17):4382-91. PubMed ID: 20534739 [TBL] [Abstract][Full Text] [Related]
5. Cordycepin induces apoptosis in human bladder cancer T24 cells through ROS-dependent inhibition of the PI3K/Akt signaling pathway. Kim SO; Cha HJ; Park C; Lee H; Hong SH; Jeong SJ; Park SH; Kim GY; Leem SH; Jin CY; Hwang EJ; Choi YH Biosci Trends; 2019; 13(4):324-333. PubMed ID: 31527329 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of phosphatidylinositol 3'-kinase/AKT signaling promotes apoptosis of primary effusion lymphoma cells. Uddin S; Hussain AR; Al-Hussein KA; Manogaran PS; Wickrema A; Gutierrez MI; Bhatia KG Clin Cancer Res; 2005 Apr; 11(8):3102-8. PubMed ID: 15837766 [TBL] [Abstract][Full Text] [Related]
7. In vivo pharmacodynamic effects of Hu1D10 (remitogen), a humanized antibody reactive against a polymorphic determinant of HLA-DR expressed on B cells. Shi JD; Bullock C; Hall WC; Wescott V; Wang H; Levitt DJ; Klingbeil CK Leuk Lymphoma; 2002 Jun; 43(6):1303-12. PubMed ID: 12153000 [TBL] [Abstract][Full Text] [Related]
8. A phase I/II dose escalation study of apolizumab (Hu1D10) using a stepped-up dosing schedule in patients with chronic lymphocytic leukemia and acute leukemia. Lin TS; Stock W; Xu H; Phelps MA; Lucas MS; Guster SK; Briggs BR; Cheney C; Porcu P; Flinn IW; Grever MR; Dalton JT; Byrd JC Leuk Lymphoma; 2009 Dec; 50(12):1958-63. PubMed ID: 19860603 [TBL] [Abstract][Full Text] [Related]
9. Albumin activates the AKT signaling pathway and protects B-chronic lymphocytic leukemia cells from chlorambucil- and radiation-induced apoptosis. Jones DT; Ganeshaguru K; Anderson RJ; Jackson TR; Bruckdorfer KR; Low SY; Palmqvist L; Prentice HG; Hoffbrand AV; Mehta AB; Wickremasinghe RG Blood; 2003 Apr; 101(8):3174-80. PubMed ID: 12480711 [TBL] [Abstract][Full Text] [Related]
10. The lethal effects of pharmacological cyclin-dependent kinase inhibitors in human leukemia cells proceed through a phosphatidylinositol 3-kinase/Akt-dependent process. Yu C; Rahmani M; Dai Y; Conrad D; Krystal G; Dent P; Grant S Cancer Res; 2003 Apr; 63(8):1822-33. PubMed ID: 12702569 [TBL] [Abstract][Full Text] [Related]
11. Regulation of Akt/PKB by phosphatidylinositol 3-kinase-dependent and -independent pathways in B-cell chronic lymphocytic leukemia cells: role of protein kinase C{beta}. Barragán M; de Frias M; Iglesias-Serret D; Campàs C; Castaño E; Santidrián AF; Coll-Mulet L; Cosialls AM; Domingo A; Pons G; Gil J J Leukoc Biol; 2006 Dec; 80(6):1473-9. PubMed ID: 16940331 [TBL] [Abstract][Full Text] [Related]
13. Flavopiridol and trastuzumab synergistically inhibit proliferation of breast cancer cells: association with selective cooperative inhibition of cyclin D1-dependent kinase and Akt signaling pathways. Wu K; Wang C; D'Amico M; Lee RJ; Albanese C; Pestell RG; Mani S Mol Cancer Ther; 2002 Jul; 1(9):695-706. PubMed ID: 12479366 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of phosphatidylinositol 3-kinase-Akt signaling blocks growth, promotes apoptosis, and enhances sensitivity of small cell lung cancer cells to chemotherapy. Krystal GW; Sulanke G; Litz J Mol Cancer Ther; 2002 Sep; 1(11):913-22. PubMed ID: 12481412 [TBL] [Abstract][Full Text] [Related]
15. Autologous plasma activates Akt/protein kinase B and enhances basal survival and resistance to DNA damage-induced apoptosis in B-chronic lymphocytic leukaemia cells. Wickremasinghe RG; Ganeshaguru K; Jones DT; Lindsay C; Spanswick VJ; Hartley JA; Wadhwa M; Thorpe R; Hoffbrand AV; Prentice HG; Mehta AB Br J Haematol; 2001 Sep; 114(3):608-15. PubMed ID: 11552986 [TBL] [Abstract][Full Text] [Related]
16. Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells. Petlickovski A; Laurenti L; Li X; Marietti S; Chiusolo P; Sica S; Leone G; Efremov DG Blood; 2005 Jun; 105(12):4820-7. PubMed ID: 15728130 [TBL] [Abstract][Full Text] [Related]
17. The role of phosphoinositide 3-kinase/Akt signaling in low-dose mercury-induced mouse pancreatic beta-cell dysfunction in vitro and in vivo. Chen YW; Huang CF; Tsai KS; Yang RS; Yen CC; Yang CY; Lin-Shiau SY; Liu SH Diabetes; 2006 Jun; 55(6):1614-24. PubMed ID: 16731823 [TBL] [Abstract][Full Text] [Related]
18. LY294002 and metformin cooperatively enhance the inhibition of growth and the induction of apoptosis of ovarian cancer cells. Li C; Liu VW; Chan DW; Yao KM; Ngan HY Int J Gynecol Cancer; 2012 Jan; 22(1):15-22. PubMed ID: 22080879 [TBL] [Abstract][Full Text] [Related]
19. Diallyl trisulfide induces osteosarcoma cell apoptosis through reactive oxygen species-mediated downregulation of the PI3K/Akt pathway. Wang H; Sun N; Li X; Li K; Tian J; Li J Oncol Rep; 2016 Jun; 35(6):3648-58. PubMed ID: 27035545 [TBL] [Abstract][Full Text] [Related]
20. Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors. Pei XY; Dai Y; Grant S Clin Cancer Res; 2004 Jun; 10(11):3839-52. PubMed ID: 15173093 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]